Prescription of heroin to treatment resistant heroin addicts

doi:10.1136/bmj.328.7433.228-a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Replacement therapies need to be tested on a level playing field

Laurence J Reed (spdpljr@iop.kcl.ac.uk), specialist registrar,
Cornelis de Wet, specialist registrar,
Jennifer Bearn, consultant

Bethlem Royal Hospital, South London and Maudsley NHS Trust, Beckenham, Kent BR3 3BX
Bethlem Royal Hospital, South London and Maudsley NHS Trust, Beckenham, Kent BR3 3BX

EDITOR—The study of medical prescription of heroin by van den Brink et al should be interpreted with caution.1

Firstly, the selection of opiate dependent patients with at least four weeks of continuous treatment in the past five years does not define resistance to treatment with methadone treatment, but rather, early treatment …